Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
2004 1
2005 1
2007 1
2008 2
2009 1
2010 1
2011 1
2012 3
2013 2
2014 7
2015 7
2016 2
2017 1
2018 2
2019 3
2020 4
2021 2
2022 7
2023 11
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Intravenous Immune Globulin in Dermatomyositis.
Aggarwal R, Charles-Schoeman C, Schessl J, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis C, Schiopu E, Vencovský J, Beckmann I, Clodi E, Bugrova O, Dankó K, Ernste F, Goyal NA, Heuer M, Hudson M, Hussain YM, Karam C, Magnolo N, Nelson R, Pozur N, Prystupa L, Sárdy M, Valenzuela G, van der Kooi AJ, Vu T, Worm M, Levine T; ProDERM Trial Group. Aggarwal R, et al. Among authors: griger z. N Engl J Med. 2022 Oct 6;387(14):1264-1278. doi: 10.1056/NEJMoa2117912. N Engl J Med. 2022. PMID: 36198179 Clinical Trial.
International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS, Callen JP, Chinoy H, Chung L, Fiorentino D, Gordon P, Machado PM, McHugh N, Selva-O'Callaghan A, Schmidt J, Tansley SL, Vleugels RA, Werth VP; International Myositis Assessment and Clinical Studies Group Cancer Screening Expert Group; Aggarwal R. Oldroyd AGS, et al. Nat Rev Rheumatol. 2023 Dec;19(12):805-817. doi: 10.1038/s41584-023-01045-w. Epub 2023 Nov 9. Nat Rev Rheumatol. 2023. PMID: 37945774 Review.
[Dermatomyositis-specific antibodies].
Bodoki L, Nagy-Vincze M, Griger Z, Dankó K. Bodoki L, et al. Among authors: griger z. Z Rheumatol. 2015 May;74(4):363-9. doi: 10.1007/s00393-014-1524-7. Z Rheumatol. 2015. PMID: 25644067 Review. German.
Pharmacological management of dermatomyositis.
Griger Z, Nagy-Vincze M, Dankó K. Griger Z, et al. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1109-1118. doi: 10.1080/17512433.2017.1353910. Epub 2017 Jul 17. Expert Rev Clin Pharmacol. 2017. PMID: 28691537 Review.
Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.
Hum RM, Lilleker JB, Lamb JA, Oldroyd AGS, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Danieli MG, Oakley P, Griger Z, Nguyen Thi Phuong T, Kodishala C, Vazquez-Del Mercado M, Andersson H, De Paepe B, De Bleecker JL, Maurer B, McCann L, Pipitone N, McHugh N, New RP, Ollier WE, Krogh NS, Vencovsky J, Lundberg IE, Chinoy H; MYONET Registry. Hum RM, et al. Among authors: griger z. Rheumatology (Oxford). 2024 Aug 1;63(8):2093-2100. doi: 10.1093/rheumatology/kead481. Rheumatology (Oxford). 2024. PMID: 37698987 Free PMC article.
[Necrotizing autoimmune myopathy].
Bodoki L, Vincze M, Hortobágyi T, Griger Z, Cseri K, Szőllősi L, Dankó K. Bodoki L, et al. Among authors: griger z. Orv Hetil. 2012 Sep 23;153(38):1502-7. doi: 10.1556/OH.2012.29450. Orv Hetil. 2012. PMID: 22985665 Review. Hungarian.
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study.
Ali SS, R N, Sen P, Day J, Joshi M, Nune A, Nikiphorou E, Saha S, Tan AL, Shinjo SK, Ziade N, Velikova T, Milchert M, Jagtap K, Parodis I, Edgar Gracia-Ramos A, Cavagna L, Kuwana M, Knitza J, Chen YM, Makol A, Agarwal V, Patel A, Pauling JD, Wincup C, Barman B, Zamora Tehozol EA, Rojas Serrano J, La Torre IG, Colunga-Pedraza IJ, Merayo-Chalico J, Chibuzo OC, Katchamart W, Goo PA, Shumnalieva R, Hoff LS, El Kibbi L, Halabi H, Vaidya B, Shaharir SS, Hasan ATMT, Dey D, Gutiérrez CET, Caballero-Uribe CV, Lilleker JB, Salim B, Gheita T, Chatterjee T, Distler O, Saavedra MA, Chinoy H, Agarwal V, Aggarwal R, Gupta L; COVAD Study Group. Ali SS, et al. Rheumatology (Oxford). 2023 Sep 1;62(9):e263-e268. doi: 10.1093/rheumatology/kead149. Rheumatology (Oxford). 2023. PMID: 37004201 No abstract available.
[Biological therapy in idiopathic inflammatory myopathies].
Bodoki L, Nagy-Vincze M, Griger Z, Péter A, András C, Dankó K. Bodoki L, et al. Among authors: griger z. Orv Hetil. 2014 Jan 5;155(1):3-10. doi: 10.1556/OH.2014.29787. Orv Hetil. 2014. PMID: 24379090 Review. Hungarian.
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
Aggarwal R, Schessl J, Charles-Schoeman C, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Beckmann I, Clodi E, Levine T; ProDERM investigators. Aggarwal R, et al. Among authors: griger z. Arthritis Res Ther. 2024 Jan 17;26(1):27. doi: 10.1186/s13075-023-03232-2. Arthritis Res Ther. 2024. PMID: 38233885 Free PMC article. Clinical Trial.
66 results